Yusimry 40 mg/0.8 mL single-dose pen Images
Generic Name: adalimumab
This medication has been identified as Yusimry 40 mg/0.8 mL single-dose pen and is used for Ankylosing Spondylitis, Crohn's Disease, Crohn's Disease, Active, Crohn's Disease, Maintenance, and Hidradenitis Suppurativa. It belongs to the drug class TNF alfa inhibitors and is not a controlled substance.
Images of medication
Yusimry
- Generic Name
- adalimumab
- Strength
- 40 mg/0.8 mL single-dose pen
- Availability
- Prescription only
- Drug Class
- TNF alfa inhibitors
- Pregnancy Category
- B - No proven risk in humans
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Coherus BioSciences, Inc.
- National Drug Code (NDC)
- 70114-0220
See also:
More about Yusimry (adalimumab)
- Check interactions
- Compare alternatives
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: TNF alfa inhibitors
- Breastfeeding
Patient resources
Other brands
Humira, Hyrimoz, Hadlima, Amjevita, ... +6 more
Professional resources
Other brands
Humira, Hyrimoz, Hadlima, Amjevita, ... +6 more
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.